Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eyyup Cavdar

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Medicina (Kaunas, Lithuania)|May 25, 2024
Clinicopathologic Analysis and Prognostic Factors for Survival in Patients with Operable Ampullary Carcinoma: A Multi-Institutional Retrospective ExperienceNebi Serkan Demirci, Eyyup Cavdar, Nuriye Yildirim Ozdemir, et al.
Journal of Cancer Research and Therapeutics|June 14, 2023
Decrease in estimated glomerular filtration rates in non-small cell lung cancer patients treated with crizotinibYakup Iriagac, Eyyup Cavdar, Kubilay Karaboyun, et al.
Cancers|July 27, 2024
A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC PatientsSedat Yildirim, Akif Dogan, Goncagul Akdag, et al.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|January 8, 2024
Efficacy of Neoadjuvant Chemotherapy in Lobular and Rare Subtypes of Breast CancerErdogan Selcuk Seber, Yakup Iriagac, Eyyup Cavdar, et al.
Cancers|September 13, 2025
FOLFIRINOX: The Best Adjuvant Treatment for Ampullary Adenocarcinoma? A Multicenter Study by the Turkish Oncology Group (TOG)Ali Kalem, Tulay Kus, Taha Koray Sahin, et al.
Molecular and Clinical Oncology|April 29, 2025
Real‑world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group retrospective studyAlpaslan Ozgun, Fatma Nihan Akkoc Mustafayev, Izzet Dogan, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Medicina (Kaunas, Lithuania)|May 25, 2024
Clinicopathologic Analysis and Prognostic Factors for Survival in Patients with Operable Ampullary Carcinoma: A Multi-Institutional Retrospective ExperienceNebi Serkan Demirci, Eyyup Cavdar, Nuriye Yildirim Ozdemir, et al.
Journal of Cancer Research and Therapeutics|June 14, 2023
Decrease in estimated glomerular filtration rates in non-small cell lung cancer patients treated with crizotinibYakup Iriagac, Eyyup Cavdar, Kubilay Karaboyun, et al.
Cancers|July 27, 2024
A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC PatientsSedat Yildirim, Akif Dogan, Goncagul Akdag, et al.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|January 8, 2024
Efficacy of Neoadjuvant Chemotherapy in Lobular and Rare Subtypes of Breast CancerErdogan Selcuk Seber, Yakup Iriagac, Eyyup Cavdar, et al.
Cancers|September 13, 2025
FOLFIRINOX: The Best Adjuvant Treatment for Ampullary Adenocarcinoma? A Multicenter Study by the Turkish Oncology Group (TOG)Ali Kalem, Tulay Kus, Taha Koray Sahin, et al.
Molecular and Clinical Oncology|April 29, 2025
Real‑world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group retrospective studyAlpaslan Ozgun, Fatma Nihan Akkoc Mustafayev, Izzet Dogan, et al.
Pageof 2